DANIELLE SABALA: Open Payments
NPI 1508412909 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,088 in 109 payments from 24 companies in 2025. Trend: 2023 $2,516 · 2024 $2,276 · 2025 $2,088
Food & beverage: $2,088
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $288 |
| Vanda Pharmaceuticals Inc. | 8 | $245 |
| AstraZeneca Pharmaceuticals LP | 8 | $242 |
| PFIZER INC. | 9 | $206 |
| Otsuka America Pharmaceutical, Inc. | 11 | $168 |
| Merck Sharp & Dohme LLC | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $105 |
| Corcept Therapeutics | 4 | $88 |
| Grifols USA, LLC | 4 | $78 |
| Novo Nordisk Inc | 4 | $75 |
Products named: FANAPT, REXULTI, FARXIGA, NURTEC ODT, UBRELVY, CAPLYTA, VERQUVO, QULIPTA.
Industry payments across MI — which companies pay providers there.
